Connect with us

Energy & Critical Metals

Dear XPEV Stock Fans, Here Are 2 Big Reasons to Celebrate

Today, investors in Chinese electric vehicle (EV) company Xpeng (NYSE:XPEV) and XPEV stock are seeing some red. It appears Chinese stocks are once again…

Share this article:



This article was originally published by Investor Place

Today, investors in Chinese electric vehicle (EV) company Xpeng (NYSE:XPEV) and XPEV stock are seeing some red. It appears Chinese stocks are once again in selloff mode, following a series of negative news items that have plagued this sector this week.

Source: Andy Feng /

Among the key things investors in Chinese equities are watching right now, Chinese growth underwhelmed investors. This past month’s economic growth was vastly lower than what economists and investors were expecting. This has led to concerns about the global recovery coming out of this pandemic slowing.

Additionally, concerns about other regulatory mandates related to the breaking up of Ant Group and plummeting bond prices for Chinese property developers has investors on edge.

However, when it comes to EV-related stocks, this is a sector that has just recently fallen under scrutiny. China’s industry minister recently commented that there are “too many” EV makers in China. Accordingly, consolidation in this sector is expected. However, who will ultimately be acquired or pushed out remains to be seen.

For Xpeng, one of the smaller players in this sector, one might think this is actually a good thing. Should Xpeng be swallowed up, investors may be paid a nice premium for their shares. That said, how things are done in China may be slightly different than what we’re used to here at home. Accordingly, investors don’t seem too happy with any sort of negative commentary from regulators on a given sector right now.

That said, there are two key reasons investors in XPEV stock may want to celebrate. Let’s dive into two bullish catalysts for this stock, on a down day for Xpeng.

2 Reasons to Be Bullish on XPEV Stock

Today, a Reuters report highlighted the possibility Xpeng could be in the market for acquisitions. The company is reportedly considering acquiring smaller, less successful rivals. Such a move would be intended to boost production capacity, as the company scales up production.

Indeed, the speed at which Chinese EV makers can ramp up production has been a key issue for investors. A global chip shortage has threatened the growth trajectories of companies in this sector. However, combining forces could be exactly what the industry minister wants. Accordingly, this should be viewed as good news by investors.

Additionally, Xpeng has also reportedly launched its third production model. The company calls its XPeng P5 model a “smart family sedan,” though the electric vehicle does appear to be more of a crossover/small SUV from initial photos.

The pricing for this smart family sedan is slated to come in at the equivalent of approximately $24,500 to $34,500. Investors bullish on Xpeng’s ability to capture more market share among the middle class may certainly like this announced addition. Furthermore, deliveries are expected to commence later in October.

These announcements certainly are bullish. However, sentiment among Chinese equities remains a key headwind these stocks will face. Accordingly, XPEV stock will be an interesting one to watch from here.

On the date of publication, Chris MacDonald did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

More From InvestorPlace

The post Dear XPEV Stock Fans, Here Are 2 Big Reasons to Celebrate appeared first on InvestorPlace.

Energy & Critical Metals

Nio Stock’s Slide Likely Isn’t Over as Broader Correction Looms

When I wrote about Nio (NYSE:NIO) last month, I argued that the risks that could send NIO stock lower outweighed factors that could help it bounce back.

Share this article:

When I wrote about Nio (NYSE:NIO) last month, I argued that the risks that could send NIO stock lower outweighed factors that could help it bounce back.

Source: Robert Way /

The Chinese electric vehicle (EV) maker has numerous strengths, such as high projected rates of growth in its home market. It also has the potential to go global, first in Europe, and then possibly in other key markets like the United States.

However, I believe the company’s rich valuation and jurisdictional risk from China outweigh these positives. What’s more, the stock has taken a hit on concerns about the potential collapse of Chinese property development giant Evergrande (OTCMKTS:EGRNF).

In my opinion, NIO stock is nowhere near bottoming out and likely to move lower in the short term.

High Growth Far From Guaranteed

While NIO stock is down 47% from its all-time high of just below $67 per share, made in January, there’s still a good deal of enthusiasm surrounding the company.

The main driver of that enthusiasm is the company’s high projected levels of growth. Analysts forecast revenue will surge 120% this year and 65% in 2022.

Depending on how Nio’s expansion into Norway goes, growth from Europe could cause analysts to raise their growth forecasts. This could also help counter a growth slowdown in China. Nio faces stiff competition in the Chinese EV market from local rivals such as Xpeng (NYSE:XPEV), as well as from the likes of Tesla (NASDAQ:TSLA).

Despite the high-growth forecast, I do not expect sentiment for NIO stock to shift back to prior levels of bullishness for two reasons.

First, it’s not guaranteed that the company’s rate of growth will stay as high as it’s been in recent quarters. The global chip shortage resulted in Nio’s August vehicle deliveries falling by 25.9% on a month-over-month basis and caused management to cut its delivery outlook for the current quarter (ending Sept. 30). With the chip shortage expected to drag on, it may affect results in subsequent quarters as well. A Chinese economic slowdown, even if the Evergrande crisis gets under control, could also negatively affect sales growth going forward.

Second, the company’s European expansion could fail to deliver. If Nio stumbles in Norway, it may signal it doesn’t have what it takes to become a global EV brand.

Given these two big unknowns, I don’t see much to prevent NIO stock from tumbling if the broader market turns lower.

Downside Risk High if Appetite for Growth Stocks Wanes

With the odds of a correction climbing, it may be best to tread carefully with growth stocks. Whether caused by changes in Federal Reserve policy, or factors like slowing economic growth, it seems all the more likely that the runaway bull market is about to reverse course.

  • Missing required attributes. Please edit.

In the event of a broader market pullback or correction, investors will shift out of speculative growth plays like NIO stock and into safer plays. This is likely to be the case even if the company meets expectations.

If Nio faces the double-whammy of disappointing results and a rocky stock market, look out below. While shares probably won’t head back to the low single-digits, investors can expect an outsized pullback compared to the broader market.

The Bottom Line on NOI Stock

Hopes for this popular EV maker run high, but the ongoing chip shortage and a slowing Chinese economy may stop Nio’s revenue growth in its tracks. And the risk of a pullback is being exacerbated by a weakening broader market.

I think there is a high probability that NIO stock trades back down to $25, or even $20 per share. So, it’s best to stay away for now.

On the date of publication, Thomas Niel did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Thomas Niel, contributor for, has been writing single-stock analysis for web-based publications since 2016.

More From InvestorPlace

The post Nio Stock’s Slide Likely Isn’t Over as Broader Correction Looms appeared first on InvestorPlace.

Continue Reading

Energy & Critical Metals

Bruce Power receives regulatory approval for new lifesaving medical isotope production

  TIVERTON – Bruce Power has received approval from the Canadian Nuclear Safety Commission (CNSC) to take the next step forward for new isotope production…

Share this article:


TIVERTON – Bruce Power has received approval from the Canadian Nuclear Safety Commission (CNSC) to take the next step forward for new isotope production becoming the first power reactor globally to commercially produce Lutetium-177, an innovative therapeutic isotope used in the treatment of prostate cancer and neuroendocrine tumors.

“This Project is an innovative partnership between Bruce Power, IsoGen, Saugeen Ojibway Nation (SON) and ITM and is a game changer for the supply of medical isotopes and the global medical community in the fight against cancer,” said James Scongack, Bruce Power Chief Development Officer and EVP Operational Services. “This is another important step forward to utilize our CANDU reactors to provide a new large-scale capacity for production in the medical isotope supply chain, cementing Canada’s place as a global isotope superpower.”

Isogen is a joint venture between Framatome and Kinectrics to enable the use of CANDU reactors to produce medical isotopes needed to treat and diagnose patients with serious diseases world-wide.

“The Framatome team conducted extensive research and development in Canada and modified German technology for use in a CANDU reactor, which resulted in the first Isotope Production System in a power reactor for commercial production of therapeutic medical isotopes,” said Curtis Van Cleve, President and CEO of Framatome Canada Ltd. “We applaud our partners at Bruce Power for their commitment to innovation that supports the continuous production of both electricity and medical isotopes, and to harnessing the therapeutic power of nuclear energy.”

The Isotope Production System (IPS), designed and manufactured by Isogen, will be used to produce Lutetium-177, an isotope used in nuclear medicines that allows for targeted and precise treatments, destroying cancer cells while limiting damage to surrounding healthy tissue and organs. The irradiated Ytterbium targets obtained from the IPS will be processed at ITM premises, where the highly pure no-carrier-added (n.c.a.) Lutetium-177 will be produced in pharmaceutical quality. N.c.a. Lutetium-177 will be marketed globally by ITM under the brand name EndolucinBeta® as well as leveraged for clinical supply to advance the company’s own pipeline. ITM is a German based leading radiopharmaceutical biotech company focused on the development, production and global supply of medical radioisotopes and radiopharmaceuticals.

“The license granted by CNSC today marks a critical milestone for Isogen on our mission to provide lifesaving medical isotopes to the world,” said David Harris, CEO of Kinectrics.  “This approval showcases the advantages of bringing together the significant investments and capabilities of the partners to advance the technology, and develop the safety, engineering and licensing packages necessary to introduce such a cutting-edge technology in a safe and reliable manner without impact to normal reactor operation.”

“It is great to see the progression in the installation of the Isotope Production System, which provides us with an additional reliable source to increase the scalability of our n.c.a. Lutetium-177 production for global supply as well as the further clinical development of our broad pipeline,” commented Steffen Schuster, CEO of ITM. “We look forward to leveraging our long-term partnership with Bruce Power to deliver Targeted Radionuclide Therapy to cancer patients worldwide.”

Bruce Power’s collaboration with Saugeen Ojibway Nation (SON) will see the partners jointly marketing new isotopes in support of the global fight against cancer while also working together in creating new economic opportunities within the SON territory by establishing new isotope infrastructure.

“It’s very exciting times for SON as we move forward to the next phase of the Isotope project with Bruce Power,” said Chief Lester Anoquot, Chippewas of Saugeen First Nation.  “Many members of our community have been impacted by cancer in some way.  We are proud to play a leadership role in the global fight against cancer, while building economic opportunities in our community.”

The partnership, which includes an equity stake and revenue-sharing model for SON, is named Gamzook’aamin aakoziwin, which means ‘We are Teaming up on the Sickness’ in the traditional Anishinaabe language.

“The Gamzook’aamin aakoziwin project will positively impact people worldwide, well beyond the borders of our community,” said Chief Victoria Smith, Chippewas of Nawash Unceded First Nation.  “This project is a groundbreaking development in the fight against cancer, and represents a positive step forward for the global medical community.”

The approved project will expand Bruce Power’s established isotope production, and will solidify the company as an integral producer of critical medical isotopes increasingly being used in innovative nuclear medicine applications.

“Ontario continues to position itself as a world leader in the production of life-saving medical isotopes,” said Energy Minister Todd Smith. “The innovation of companies like Bruce Power and its partners is critical to ensuring increased capacity of isotope production to improve global access to these essential tools in the fight against cancer. Today’s announcement is a big step forward in furthering the goal of long-term, sustainable, and flexible production of medical isotopes at the Bruce Power site.”

Bruce Power is one of the world’s largest producers of Cobalt-60 through its partnership with Nordion, used in the sterilization of single use medical equipment and in transformative cancer treatments like the Gamma Knife.

“Thanks to the investments being made into the Bruce Power site today we can look to the future and realize a vital role in providing life-saving medical isotopes to the world, while also supplying clean, reliable and low-cost electricity to Ontario, growing the economy and fostering innovation for decades to come,” said Lisa Thompson, MPP for Huron-Bruce.

Bill Walker, MPP for Bruce-Grey-Owen Sound, also offered his support and congratulations.

“The potential for growth in the isotope space provides an invaluable opportunity to leverage Ontario’s established nuclear supply chain that has developed over the past several years and is recognized as a leader around the world in isotope innovation, development and production,” said Walker. “Most importantly isotopes are making a positive difference in people’s lives every day and I am proud to be a champion of the nuclear industry.”

The work to install the Isotope Production System is a part of the ongoing Life-Extension Program at the Bruce Power site, which began in 2016 and remains on track.

As the commissioning process continues there will be additional regulatory hold points to allow CNSC staff to confirm operational readiness of the Isotope Production System (IPS) prior to the start of Lu-177 production. Bruce Power will finalize documentation and CNSC staff will review commissioning test results to verify the IPS meets its design and safety analyses requirements.

Continue Reading

Energy & Critical Metals

Jelly Roll, Layer Cake or Popsicle Stick – The Evolution of Lithium-Ion Battery Shapes in EV’s

By Alf Stewart There are different forms of Lithium-Ion  batteries in use today, and two…

Share this article:

By Alf Stewart

There are different forms of Lithium-Ion  batteries in use today, and two new sizes of batteries to be introduced in the next year. This article explores the three types: pouch cells, prismatic cells and cylindrical cells. A few of the advantages of that arise from these shapes are discussed. The introduction of the Blade Battery by BYD, the largest EV manufacturer in China may signal a new trend in the shape of batteries to come

There are different forms for Lithium-Ion batteries in use today.

Pouch Cells and Prismatic Cells – Layer Cake

Pouch Cell – No hard enclosure Layer Cake
Prismatic Cell – A Layer Cake in a hard shell


Prismatic cells are made up of many positive and negative electrodes layers sandwiched together leaving more possibility for short circuit and inconsistency. The higher capacity makes it difficult to protect each cell from over charging and dissipating heat. This is the form of Lithium-Ion Battery Cell used by General Motors and Hyundai. Unfortunately, these cells have been linked to some battery fires and Elon Musk that cylindrical cells are superior for protection from overheating.

Cylindrical Cell – A Jelly Roll

These cells are rolled up layers of the positive and negative cell sandwich. Reputedly more thermally stable than prismatic cells, and they have been Tesla’s choice for all its vehicles until recently. Tesla is currently leading the charge in terms of range, energy density and safety but that title may soon pass to another form as we shall discuss.

The current generation of cylindrical cells have dimensions of 21 millimetres long by 70 millimeters in diameter. At Tesla’s Battery Day event last September, the company introduced the 46 millimeter by 80-millimeter size, the 4680 cell for its next generation battery pack. The battery pack using 4680’s will be Tesla’s own Gigafactory product, but 3rd party battery manufacturers may also supply these cells to Tesla, with final assembly into packs done at Tesla’s Berlin or Austin Gigafactories.

It is expected that the 4680 Jelly Roll style battery can be produced on an automated assembly line by the millions, but Tesla is still in the start-up phase of making these new cells at commercial scale.

The Blade Battery is an extreme form of the Prismatic Cell design with a very long and thin shape.

The Blade Battery – A Popsicle Stick – A BYD Innovation

This shape allows the batteries to be used as strong planks in a battery pack. The batteries do not have to grouped into modules, as is common with other designs. They are also extremely stable thermally as BYD demonstrated by drilling into a standard Nickel -Cobalt- Manganese Prismatic Cell and then repeating the same experiment with a Blade Battery.

Tesla has opted for prismatic cells with Lithium-Ion Phosphate Chemistry for its Standard Range Plus Model 3 made in Shanghai. It may signal the emergence of Prismatic Cells with Lithium-Ion Phosphate chemistry as the most popular flavor in the Electric Vehicle market.

Continue Reading